- Home
- QGEN vs NCLH Comparison
QGEN vs NCLH Comparison
Compare QGEN & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- NCLH
- Stock Information
- Founded
- QGEN 1986
- NCLH 1966
- Country
- QGEN Netherlands
- NCLH United States
- Employees
- QGEN N/A
- NCLH N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- NCLH Marine Transportation
- Sector
- QGEN Health Care
- NCLH Consumer Discretionary
- Exchange
- QGEN Nasdaq
- NCLH Nasdaq
- Market Cap
- QGEN 9.9B
- NCLH 9.3B
- IPO Year
- QGEN 1996
- NCLH 2013
- Fundamental
- Price
- QGEN $39.51
- NCLH $19.06
- Analyst Decision
- QGEN Buy
- NCLH Buy
- Analyst Count
- QGEN 8
- NCLH 18
- Target Price
- QGEN $49.79
- NCLH $28.76
- AVG Volume (30 Days)
- QGEN 1.1M
- NCLH 14.4M
- Earning Date
- QGEN 04-28-2025
- NCLH 04-30-2025
- Dividend Yield
- QGEN 3.29%
- NCLH N/A
- EPS Growth
- QGEN N/A
- NCLH 384.69
- EPS
- QGEN 0.38
- NCLH 1.89
- Revenue
- QGEN $1,978,214,000.00
- NCLH $9,479,651,000.00
- Revenue This Year
- QGEN $5.15
- NCLH $9.56
- Revenue Next Year
- QGEN $6.49
- NCLH $10.67
- P/E Ratio
- QGEN $105.49
- NCLH $10.08
- Revenue Growth
- QGEN 0.66
- NCLH 10.87
- 52 Week Low
- QGEN $37.63
- NCLH $14.69
- 52 Week High
- QGEN $47.93
- NCLH $29.29
- Technical
- Relative Strength Index (RSI)
- QGEN 46.28
- NCLH 35.02
- Support Level
- QGEN $39.31
- NCLH $18.19
- Resistance Level
- QGEN $40.27
- NCLH $20.88
- Average True Range (ATR)
- QGEN 0.55
- NCLH 0.80
- MACD
- QGEN 0.16
- NCLH 0.16
- Stochastic Oscillator
- QGEN 50.00
- NCLH 32.34
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.